Dr. mohamad azzam farouk ziade

Dr. Mohamad Azzam Farouk Ziade

Consultant Hematologist

LANGUAGES:

ArabicEnglishFrench

QUALIFICATION:

  • Holds a Master degree In Bone Marrow Transplantation at International Center for Transplantation in Thalassemia and Sickle Cell Anemia of the Mediterranean Institute of Haematology Rome, Italy
  • Holds a National Diploma in Medical Oncology (fellowship at University of Padua) 
  • Bachelor's Degree of Medicine and Surgery from University of Ancona
  • European Bone Marrow Transplant society membership 

 

 

PROFESSIONAL EXPERIENCE:

  • Has more than 28 years of experience in hematology and oncology
  • Worked as a Consultant Oncologist and Haematologist (Bone Marrow Transplantation in affiliation with American University Hospital Beirut) Rafik Hariri University Hospital and General Military Hospital (Beirut, Lebanon) as well as at prestigious hospitals within UAE
  • Completed his training in Haematology and Bone marrow Transplant at San Bortolo Hospital Vicenza and also Mediterranean Institute of Haematology Rome, Italy
  • Obtains many Training in Medical Oncology and Clinical Haematology (with International Leadership of prof. ponadonne, Prof. Luckarelli, and Prof. Mufti)
  • Membership of the European Society of Medical Oncology, the American Society of Clinical Oncology, the American Society of Haematology, and European Bone Marrow Transplant Society
  • Participated in presenting many national and international protocols, Abstracts, and many different articles in well-known international Journals

INTERESTS:

  • Haemoglobinopathy mainly Thalassemia, Sickle Cell anemia Treatment including Bone Marrow 
  • Haematological diseases 
  • Hereditary and acquired disorders of hemostasis and Thrombophilia (these are disorders of the vascular wall, platelet count, and platelet function)
  • Management of all of the types of Solid tumors (Screening, Diagnosis, Staging, Treatment including Chemotherapy, Immunotherapy, and target treatment
  • Melanoma
  • Brain tumors
  • Autologous stem cell transplantation for lymphomas, multiple myeloma, carcinomas, and allogenic transplant